(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ICHNOS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ICHNOS

ST13

US500000079290390

Class

3, 5, 10, 35, 41, 42, 44, 45

Filing

79290390

Registration

6413608

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

07/13/2026

Trademark type

Word

Nice classes

3, 5, 10, 35, 41, 42, 44, 45

Filing date

05/06/2020

Registration date

07/13/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/13/2021

Last transaction

07/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

33

Owner location

CH

Examiner

VELTEN, MALLORY KATE

Law office

N50

Current location

TMO LAW OFFICE 123

Holders and representatives

Holders

Ichnos Sciences SA

Representatives

Jeffrey H. Greger Hauptman Ham, LLP

Technical classification

Nice Classes

Class 3Class 5Class 10Class 35Class 41Class 42Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Soaps for cosmetic usecosmetic soaps; skin soaps; shampoos; sunscreens for cosmetic use; perfumery productsperfumerydeodorants for personal use; essential oils; body powders; cosmetic productscosmetics; antiaging creams; hair lotions; cosmetic skin care preparations; skin creams; skin moisturizing gels; face washing creamsfacial cleanserswashing products for facial treatment in the nature of non-medicated soaps; moisturizing body lotions; non-medicinal mouthwashes

Class 5

Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparationsinhaler preparations for treatment of Chronic Obstructive Pulmonary Disease (COPD); preparations containing opium alkaloids; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive cold preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances used in the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation used in the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; dermatological pharmaceutical preparations; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparationsantidepressants; pharmaceutical preparationsappetite suppressants; pharmaceutical preparationsblood clotting aid and delivery systems for use in human and veterinary medicine; pharmaceutical preparationsdrug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparationsanticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparationsgels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations for preventing swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint diseases; pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticalsanti-infectives; pharmaceuticalsantihelminthics; pharmaceuticalsinducers of erections; pharmaceuticalslipid lowering agents; analgesic preparations; preparations for the treatment of asthma; preparations for therapeutic or medical purposestherapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays * ; pharmaceutical products for the treatment of erectile dysfunction; pharmaceuticals for the treatment of erectile dysfunction *

Class 10

Medical apparatus and instrumentsspirometers; medical devicesnasal sprayers in the nature of nasal irrigation vesselsinhalers and nebulizers sold empty; medical devicesautoanalysers; chromatographic medical diagnostic apparatus for testing cancer cells

Class 35

Campaigns for patient support programsadvertising services promoting public awareness of cancer patientspain managementskin carediabetes managementasthma managementchronic obstructive pulmonary disease (COPD) management and of respiratory disease management

Class 41

Educational servicesproviding workshops and seminars in the fields of cancer treatmentoncologyimmunology and pain management; publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education servicesconducting online instruction and courses in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; provision of educational contentproviding on-line instruction in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; training in the use and operation of medical devicesmedical imaging apparatus and medical research apparatus and consultation relating thereto; educational servicesconducting live and online seminarsclassesworkshopslecturespanel discussionstraining programs in the field of pharmaceutical productshealthcare and medical diseasesdisorders and related treatments; educational servicesproviding non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education servicesdevelopingarranging and conducting educational programs and providing courses of instruction in the fields of healthcarepharmaceuticalsmedical devicesmedical researchsurgerymedical science and medicine; providing training programs and developing training programs in the nature of learning methodologies for others relating to the use and operation of medical devicesmedical research apparatus and consultation relating thereto; providing online non-downloadable publicationsinstructional materials in the nature of worksheets and textbooksfeaturing study materials in the field of pharmaceutical productshealthcare and medical diseasesdisorders and related treatments; conducting educational seminars in the fields of healthcarethe use of pharmaceuticalsmedical devicesmedical researchsurgerymedical science and medicine

Class 42

Scientific research for medical purposes in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological servicesscientific researchanalysistesting in the field of oncologyimmunology and pain management; medical research in the fields of oncologyimmunology and pain management; clinical research in the fields of oncologyimmunology and pain management; scientific research and development; pharmaceutical drug development services; research and development for new products for others; chemicalpharmaceuticalnutraceutical and nutritional analysis and research; dermo-cosmetic and biotechnological analysis and research; design and testing for new product development; diagnostic product testing and analysismedical research and new product research for industrial use; scientific research in the fields of chemistrybiotechnology and pharmacology; medical and pharmaceutical research servicesscientific research services for medical purposes in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and biosimilarsbacteriological research servicesbiomedical research serviceslaboratory research services in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and biosimilarsclinical trial services in the nature of conducting clinical trials for otherspharmacological research servicesmedical research laboratory services in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and biosimilarsscientific and technological services and research and design relating theretoscientific researchanalysistesting in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and biosimilars * ; pharmaceutical research and development *

Class 44

Providing information in the field of medicine and health in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and dietetic advisory services; medical services in the field of oncologypain management; dermatologydiabetologyrespiratory disease and dietetic advisory services; medical assistance in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncologypain managementdermatologydiabetologyrespiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancerpain managementskin caremanagement of diabetesmanagement of asthmaChronic Obstructive Pulmonary Disease (COPD) and respiratory diseases

Class 45

Licensing of patents; licensing of trademarks; intellectual property licensing in the nature of licensing of intellectual property rights

Publications

History of USPTO decisions and trademark events.

41 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/13/2026

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

12/07/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

11/15/2022

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

03/15/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/15/2022

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

03/15/2022

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

03/07/2022

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

12/25/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

12/25/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/29/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/10/2021

FIMP

FINAL DISPOSITION PROCESSED

11/10/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/13/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

07/13/2021

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

06/10/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

06/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/27/2021

PUBO

PUBLISHED FOR OPPOSITION

04/27/2021

GPNX

NOTIFICATION PROCESSED BY IB

04/24/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/07/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/07/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/07/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/23/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

03/23/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/23/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

03/23/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/23/2021

DOCK

ASSIGNED TO EXAMINER

03/23/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/05/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/05/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/07/2020

RFNT

REFUSAL PROCESSED BY IB

09/27/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/07/2020

RFRR

REFUSAL PROCESSED BY MPU

09/03/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/04/2020

MAFR

APPLICATION FILING RECEIPT MAILED

08/04/2020

CNRT

NON-FINAL ACTION WRITTEN

08/03/2020

DOCK

ASSIGNED TO EXAMINER

07/31/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/31/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/30/2020

Continuous trademark protection

Get notified about every new filing that threatens ICHNOS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.